Cargando…
COVID-19 vaccination and cancer immunotherapy: should they stick together?
The combination of COVID-19 vaccination with immunotherapy by checkpoint inhibitors in cancer patients could intensify immunological stimulation with potential reciprocal benefits. Here, we examine more closely the possible adverse events that can arise in each treatment modality. Our conclusion is...
Autores principales: | Brest, Patrick, Mograbi, Baharia, Hofman, Paul, Milano, Gerard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603902/ https://www.ncbi.nlm.nih.gov/pubmed/34799696 http://dx.doi.org/10.1038/s41416-021-01618-0 |
Ejemplares similares
-
More light on cancer and COVID-19 reciprocal interaction
por: Brest, Patrick, et al.
Publicado: (2021) -
Host genetic variability and determinants of severe COVID-19
por: Brest, Patrick, et al.
Publicado: (2023) -
Using Genetics To Dissect SARS-CoV-2 Infection
por: Brest, Patrick, et al.
Publicado: (2021) -
Host Polymorphisms May Impact SARS-CoV-2 Infectivity
por: Brest, Patrick, et al.
Publicado: (2020) -
Daily Practice Assessment of KRAS Status in NSCLC Patients: A New Challenge for the Thoracic Pathologist Is Right around the Corner
por: Bontoux, Christophe, et al.
Publicado: (2022)